Table Of Contents
1 Introduction 22
1.1 Objectives Of The Study 22
1.2 Market Definition 22
1.3 Overview Of Europe Antimicrobial Susceptibility Testing Market 22
1.4 Currency And Pricing 23
1.5 Limitation 23
1.6 Markets Covered 24
2 Market Segmentation 26
2.1 Markets Covered 26
2.2 Geographic Scope 27
2.3 Years Considered For The Study 28
2.4 Currency And Pricing 28
2.5 Research Methodology 29
2.6 Primary Interviews With Key Opinion Leaders 32
2.7 The Category Vs Time Grid 33
2.8 DBMR Market Challenge Matrix 34
2.9 Secondary Sources 35
2.10 Assumptions 35
3 Market Overview 36
3.1 Drivers 38
3.1.1 Increase In Number Of Infectious Disease 38
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods 39
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use 40
3.1.4 Increased Funding, Research Grants, And Public-Private Investments 41
3.2 Restraints 42
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems 42
3.3 Opportunities43
3.3.1 Emerging Markets To Offer Lucrative Opportunities 43
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance 44
3.4 Challenges 45
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers 45
4 Executive Summary 46
5 Premium Insights 48
6 Europe Antimicrobial Susceptibility Testing Market, By Product 50
6.1 Overview 51
6.2 Manual 53
6.2.1 Susceptibility Testing Disks 54
6.2.2 Mic Strips 55
6.2.3 Susceptibility Plates 55
6.2.4 Antimicrobial Susceptibility Testing Culture Media 56
6.2.5 Consumables 56
6.3 Automated 57
6.3.1 Susceptibility Plates 58
6.3.2 Automated Instruments 59
6.3.3 Susceptibility Plate Ancillaries 59
7 Europe Antimicrobial Susceptibility Testing Market, By Methods 60
7.1 Overview 61
7.2 Dilution Methods 62
7.3 Disk Diffusion Method 63
7.4 E- Test 64
7.5 Genotypic Methods 66
7.6 Automated Systems 67
8 Europe Antimicrobial Susceptibility Testing Market, By Application 68
8.1 Overview 69
8.2 Clinical Diagnostics 70
8.3 Drug Discovery And Development 71
8.4 Epidemiology 72
8.5 Others 74
9 Europe Antimicrobial Susceptibility Testing Market, By End User 75
9.1 Overview 76
9.2 Hospitals 78
9.3 Pharmaceutical And Biotechnology Companies 80
9.4 Diagnostic Laboratories 81
9.5 Research And Academic Institutes 82
9.6 Contract Research Organizations 83
?
10 Europe Antimicrobial Susceptibility Testing Market, By Geography 84
10.1 Europe 84
10.1.1 Germany 91
10.1.2 France 94
10.1.3 United Kingdom 97
10.1.4 Italy 100
10.1.5 Spain 103
10.1.6 Russia 106
10.1.7 Turkey 109
10.1.8 Belgium 112
10.1.9 Netherlands 115
10.1.10 Switzerland 118
10.1.11 Rest Of Europe 121
11 Europe Antimicrobial Susceptibility Testing Market,
Company Landscape 122
11.1 Company Share Analysis; Europe 122
12 Company Profiles 123
12.1 Biom?rieux Sa Company 123
12.1.1 Overview 123
12.1.2 Revenue Analysis 123
12.1.3 Company Share Analysis 124
12.1.4 Product Portfolio 124
12.1.5 Recent Developments 125
12.2 Thermo Fisher Scientific Inc. 127
12.2.1 Company Overview 127
12.2.2 Revenue Analysis 127
12.2.3 Company Share Analysis 128
12.2.4 Product Portfolio 128
12.2.5 Recent Developments 131
12.3 Bd 132
12.3.1 Company Overview 132
12.3.2 Revenue Analysis 132
12.3.3 Company Share Analysis 133
12.3.4 Product Portfolio 133
12.3.5 Recent Developments 134
?
12.4 Accelerate Diagnostics, Inc. 136
12.4.1 Company Overview 136
12.4.2 Revenue Analysis 136
12.4.3 Product Portfolio 136
12.4.4 Recent Developments 137
12.5 Alifax Holding S.P.A. 138
12.5.1 Company Overview 138
12.5.2 Geographic Presence 138
12.5.3 Product Portfolio 139
12.5.4 Recent Developments 139
12.6 Bio-Rad Laboratories Inc. 140
12.6.1 Company Overview 140
12.6.2 Revenue Analysis 140
12.6.3 Product Portfolio 141
12.6.4 Recent Developments 141
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti. 142
12.7.1 Company Overview 142
12.7.2 Product Portfolio 142
12.7.3 Recent Developments 142
12.8 Conda 143
12.8.1 Company Overview 143
12.8.2 Geographic Presence 143
12.8.3 Product Portfolio 144
12.8.4 Recent Developments 145
12.9 Creative Diagnostics 146
12.9.1 Company Overview 146
12.9.2 Geographic Presence 146
12.9.3 Product Portfolio 147
12.9.4 Recent Developments 147
12.10 Genefluidics Inc.148
12.10.1 Company Overview 148
12.10.2 Product Portfolio 148
12.10.3 Recent Developments 148
12.11 Himedia Laboratories 149
12.11.1 Company Overview 149
12.11.2 Geographic al Presence 149
12.11.3 Product Portfolio 150
12.11.4 Recent Developments 151
?
12.12 Liofilchem Srl. 152
12.12.1 Company Overview 152
12.12.2 Product Portfolio 152
12.12.3 Recent Developments 153
12.13 Merck Millipore 154
12.13.1 Company Overview 154
12.13.2 Geographic Presence 154
12.13.3 Product Portfolio 155
12.13.4 Recent Developments 155
12.14 Zhuhai Dl Biotech. Co., Ltd 156
12.14.1 Company Overview 156
12.14.2 Product Portfolio 156
12.14.3 Recent Developments 156
13 Related Reports 157
?